Page last updated: 2024-11-01

ondansetron and Chorea

ondansetron has been researched along with Chorea in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Chorea: Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erdinç, OO1
Ozdemir, G1
Uysal, S1
Gücüyener, D1
Torun, S1

Other Studies

1 other study available for ondansetron and Chorea

ArticleYear
Improvement of hemichorea with ondansetron.
    Postgraduate medical journal, 1997, Volume: 73, Issue:856

    Topics: Anti-Anxiety Agents; Chorea; Humans; Male; Middle Aged; Ondansetron

1997